Table 5

- Association between associated factors with management modalities (multivariate regression analysis).

Associated factorsMultivariate regression analysis Adjusted OR (95% CI; P-value)
Best medical therapyCABGPCI
Age groups
≤60 yearsRef.4.27 (1.55-11.8); p=0.005*1.26 (0.33-4.89); p:0.738
>60 yearsRef.11
Gender
MaleRef.------0.31 (0.07-1.39); p:0.126
FemaleRef.------1
Smoking status
Current/ex-smokerRef.0.98 (0.33-2.87); p=0.965------
Non- smokerRef.1------
Diabetes mellitus
YesRef.------4.07 (0.81-20.4); p=0.089
NoRef.------1
Hypertension
YesRef.------0.85 (0.19-3.68); p=0.824
NoRef.------1
Dyslipidemia
YesRef.------1.42 (0.29-6.99); p=0.670
NoRef.------1
Diagnosis
Atypical anginaRef.1.63 (0.41-6.63); p=0.4901.14 (0.14-9.24); p=0.905
Stable anginaRef.1.57 (0.09-24.73); p=0.751-------
Unstable anginaRef.1.23 (0.35-4.29); p=0.7470.72 (0.10-5.22); p=0.748
NSTEMIRef.0.894 (0.21-3.89); p=0.8810.72 (0.09-5.93); p=0.761
STEMIRef.11
LM lesion
YesRef.4.94 (1.47-16.61); p=0.010*------
NoRef.1-------
LAD lesion
YesRef.0.83 (0.08-8.75); p=0.8750.088 (0.01-0.79); p=0.030*
NoRef.11
Ramus
YesRef.6.88 (1.77-26.79); p=0.005*------
NoRef.1------
LCX
YesRef.1.71 (0.46-6.35); p=0.4221.36 (0.22-8.25); p=0.739
NoRef.11
RCA
YesRef.1.64 (0.59-4.55); p=0.34214.6 (2.29-93.1); p=0.005*
NoRef.11
Dominant artery
RightRef.5.67 (0.91-35.4); p=0.0630.33 (0.06-1.90); p=0.213
LeftRef.1.16 (0.12-10.98); p=0.9000.12 (0.01-1.16); p=0.067
BothRef.11
MVD
YesRef.13.13 (0.60-285.7); p=0.1010.95 (0.04-20.9); p=0.975
NoRef.11
  • Significance levels: for unadjusted/univariate analysis <0.25, for multivariate analysis <0.05. Multinomial logistic regression used. The reference category is: “best medical therapy”. OR: odd ratio (95% confidence interval). PCI: percutaneous coronary intervention, CABG: coronary artery bypass grafting, NSTEMI: non-ST-elevation myocardial infarction, STEMI: ST-elevation myocardial infarction, LM: left main lesion, RCA: right coronary arteries, LAD: left anterior descending artery, LCX: left circumflex artery, MVD: coronary microvascular disease,

  • * statistically significance value